Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, NY
Sitagliptin Dose Determination Study in Type 1 Diabetes
The main purpose of this study is to see if the study medication Januvia (a pill) improves after meal blood sugars along with insulin in kids and adults with newly diagnosed Type 1 Diabetes and established diabetes. We will also compare how quickly food leaves the stomach during different parts of the study. Study includes 5 outpatient visits over a 6 to 9 month period for out of which 4 are about 11 hour long visits. You will be compensated to a total of 750 dollars for the entire study.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 180689
Date Last Changed:
July 19, 2013
Jeniece Trast, RN, CDE, MA, Clinical Research Nurse ManagerThe Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & MontefioreMontefiore Medical Center
Division of Pediatric Endocrinology
111 East 210th StreetBronx, NY 10467Phone: 718-741-2542
Research Center Information: The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.